Craig Hallum Issues Positive Forecast for KORU Medical Systems (NASDAQ:KRMD) Stock Price

KORU Medical Systems (NASDAQ:KRMD) had its price target hoisted by Craig Hallum from $4.00 to $5.00 in a report published on Thursday,Benzinga reports. The firm currently has a buy rating on the stock.

Other research analysts have also issued reports about the stock. Canaccord Genuity Group upped their price objective on shares of KORU Medical Systems from $3.00 to $4.00 and gave the stock a “buy” rating in a report on Thursday. Piper Sandler upped their target price on shares of KORU Medical Systems from $3.00 to $3.50 and gave the stock an “overweight” rating in a research report on Thursday. Finally, B. Riley initiated coverage on shares of KORU Medical Systems in a research report on Thursday, July 25th. They issued a “buy” rating and a $4.00 target price on the stock.

KORU Medical Systems Trading Up 2.9 %

NASDAQ:KRMD traded up $0.09 during midday trading on Thursday, reaching $3.17. 55,159 shares of the stock traded hands, compared to its average volume of 114,489. The company has a fifty day moving average of $2.65 and a 200 day moving average of $2.47. KORU Medical Systems has a 12 month low of $1.98 and a 12 month high of $3.40. The company has a debt-to-equity ratio of 0.01, a quick ratio of 3.27 and a current ratio of 3.77. The stock has a market capitalization of $145.34 million, a P/E ratio of -12.48 and a beta of 0.41.

Institutional Investors Weigh In On KORU Medical Systems

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Aaron Wealth Advisors LLC bought a new stake in shares of KORU Medical Systems during the second quarter valued at approximately $28,000. Allspring Global Investments Holdings LLC purchased a new position in shares of KORU Medical Systems in the second quarter valued at $28,000. Legato Capital Management LLC purchased a new position in shares of KORU Medical Systems in the second quarter valued at $35,000. Virtu Financial LLC purchased a new position in shares of KORU Medical Systems in the first quarter valued at $63,000. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of KORU Medical Systems in the second quarter valued at $107,000. Institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.